BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32641023)

  • 1. Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.
    Wollersheim BM; van Asselt KM; van der Poel HG; van Weert HCPM; Hauptmann M; Retèl VP; Aaronson NK; van de Poll-Franse LV; Boekhout AH
    BMC Cancer; 2020 Jul; 20(1):635. PubMed ID: 32641023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.
    Høeg BL; Bidstrup PE; Karlsen RV; Friberg AS; Albieri V; Dalton SO; Saltbæk L; Andersen KK; Horsboel TA; Johansen C
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31750936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.
    Ezendam NPM; de Rooij BH; Kruitwagen RFPM; Creutzberg CL; van Loon I; Boll D; Vos MC; van de Poll-Franse LV
    Trials; 2018 Apr; 19(1):227. PubMed ID: 29661218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
    Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
    Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.
    Wilt TJ; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 2):1910-4. PubMed ID: 7523736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial.
    Khan I; Taylor SJC; Robinson C; Moschopoulou E; McCrone P; Bourke L; Thaha M; Bhui K; Rosario D; Ridge D; Donovan S; Korszun A; Little P; Morgan A; Quentin O; Roylance R; White P; Chalder T
    Trials; 2024 Apr; 25(1):228. PubMed ID: 38566197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
    Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
    Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer survivors' preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry.
    Huibertse LJ; van Eenbergen M; de Rooij BH; Bastiaens MT; Fossion LM; de la Fuente RB; Kil PJ; Koldewijn EL; Meier AH; Mommers RJ; Niemer AQ; Oddens JR; Oomens EH; Prins M; de Roos KP; Thissen MR; Timmermans MW; Wijsman BP; van de Poll-Franse LV; Ezendam NP
    Acta Oncol; 2017 Feb; 56(2):278-287. PubMed ID: 28068157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors.
    Luigjes-Huizer YL; van der Lee ML; de Wit NJ; Helsper CW
    BMJ Open; 2019 Dec; 9(12):e032616. PubMed ID: 31796488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Cost-)effectiveness of an internet-based physical activity support program (with and without physiotherapy counselling) on physical activity levels of breast and prostate cancer survivors: design of the PABLO trial.
    van de Wiel HJ; Stuiver MM; May AM; van Grinsven S; Aaronson NK; Retèl VP; Oldenburg HSA; van der Poel HG; Horenblas S; van Harten WH; Groen WG
    BMC Cancer; 2018 Nov; 18(1):1073. PubMed ID: 30400784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GP experience and understandings of providing follow-up care in prostate cancer survivors in England.
    Margariti C; Gannon KN; Walsh JJ; Green JSA
    Health Soc Care Community; 2020 Sep; 28(5):1468-1478. PubMed ID: 32106357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial.
    Skolarus TA; Metreger T; Hwang S; Kim HM; Grubb RL; Gingrich JR; Hawley ST
    Trials; 2017 Apr; 18(1):181. PubMed ID: 28420419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors.
    Leermakers L; Döking S; Thewes B; Braamse AMJ; Gielissen MFM; de Wilt JHW; Collette EH; Dekker J; Prins JB
    BMC Cancer; 2018 Jul; 18(1):748. PubMed ID: 30021555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial protocol (GRIP study): examining the effect of involvement of a general practitioner and home care oncology nurse after a cancer diagnosis on patient reported outcomes and healthcare utilization.
    Perfors IAA; Helsper CW; Noteboom EA; van der Wall E; de Wit NJ; May AM
    BMC Cancer; 2018 Feb; 18(1):132. PubMed ID: 29402234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors.
    Schofield-Robinson OJ; Lewis SR; Smith AF; McPeake J; Alderson P
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012701. PubMed ID: 30388297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer.
    Emery J; Doorey J; Jefford M; King M; Pirotta M; Hayne D; Martin A; Trevena L; Lim T; Constable R; Hawks C; Hyatt A; Hamid A; Violet J; Gill S; Frydenberg M; Schofield P
    BMJ Open; 2014 Mar; 4(3):e004972. PubMed ID: 24604487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.